Article
A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency.
International journal of biological macromolecules - 1 Nov 2017
Boonyuen Usa, Chamchoy Kamonwan, Swangsri Thitiluck, Junkree Thanyaphorn, Day Nicholas P J, White Nicholas J, Imwong Mallika
Abstract excerpt
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common polymorphism and enzymopathy in humans, affecting approximately 400 million people worldwide. It is responsible for various clinical manifestations, including favism, hemolytic anemia, chronic non-spherocytic hemolytic anemia, spontaneous abortion, and neonatal hyperbilirubinemia. Understanding the molecular mechanisms underlying the severity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
